Rosenthal, A., Kumar, S., Hofmeister, C., Laubach, J., Vij, R., Dueck, A., . . . Stewart, A. K. (2015). A Phase Ib Study of the combination of Aurora Kinase Inhibitor alisertib (MLN8237) and bortezomib in Relapsed or Refractory Multiple Myeloma. Br J Haematol.
Citação norma ChicagoRosenthal, Allison, Shaji Kumar, Craig Hofmeister, Jacob Laubach, Ravi Vij, Amylou Dueck, Katherine Gano, e A. Keith Stewart. "A Phase Ib Study of the Combination of Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed or Refractory Multiple Myeloma." Br J Haematol 2015.
Citação norma MLARosenthal, Allison, et al. "A Phase Ib Study of the Combination of Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed or Refractory Multiple Myeloma." Br J Haematol 2015.